Aster DM Healthcare Limited has announced that a meeting of its Board of Directors is scheduled for Thursday, April 30, 2026. The primary objective of the meeting is to consider and approve the company’s audited standalone and consolidated financial results for the fourth quarter (Q4) and the full financial year ending March 31, 2026.
Upcoming Board Meeting
Aster DM Healthcare Limited has formally notified the stock exchanges that its Board of Directors will convene on April 30, 2026. This strategic meeting is dedicated to the review and official approval of the company’s financial performance for the period concluding on March 31, 2026.
Financial Reporting Focus
During this session, the board will evaluate both the standalone and consolidated audited financial results. This reporting covers the final quarter of the fiscal year 2025-26, as well as the aggregate financial data for the entire year. Investors and stakeholders can expect the release of these results following the conclusion of the board proceedings, providing insights into the company’s fiscal health and annual performance metrics.
Source: BSE
